Stoke Therapeutics

STOK

NASDAQHealth Care

Income Statement

Total Revenue$36.56M

Gross Profit$36.56M

Operating Income$-101.37M

EBITDA$-97.18M

EBIT$-101.62M

Pre-tax Income$-6.89M

Net Income$-88.98M

Cash Equivalent$162.71M

Total Debt$0

Book Value$211.05M

Book Value Per Share4.14

Return on Equity (ROE)-38.85%

Return on Assets (ROA)-32.77%

Return on Invested Capital (ROI)-38.85%

Net Profit Margin-243.42%

Current Ratio5.81

Quick Ratio5.53

Long-Term Debt / Equitynull